Profile
Full Name
Citius Pharmaceuticals, Inc.Ticker Symbol
CTXRExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 2, 2014Indexes
Not includedWebsite
http://citiuspharma.comEmployees
23Key Details
Price
$0.95(-3.94%)
Market cap
$8.16M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$5.97(-7.18% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Citius Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 18, 25 D. Boral Capital
BuyJan 7, 25 D. Boral Capital
BuyDec 30, 24 D. Boral Capital
BuyNov 22, 24 D. Boral Capital
HoldNov 12, 24 HC Wainwright & Co.
BuyNov 11, 24 D. Boral Capital
BuyAug 19, 24 EF Hutton
BuyAug 8, 24 EF Hutton
BuyAug 5, 24 EF Hutton
BuyJul 15, 24 EF Hutton
BuyInstitutional Ownership
- What is the ticker symbol for Citius Pharmaceuticals?
- Does Citius Pharmaceuticals pay dividends?
- What sector is Citius Pharmaceuticals in?
- What industry is Citius Pharmaceuticals in?
- What country is Citius Pharmaceuticals based in?
- When did Citius Pharmaceuticals go public?
- Is Citius Pharmaceuticals in the S&P 500?
- Is Citius Pharmaceuticals in the NASDAQ 100?
- Is Citius Pharmaceuticals in the Dow Jones?
- When was Citius Pharmaceuticals's last earnings report?
- When does Citius Pharmaceuticals report earnings?
- Should I buy Citius Pharmaceuticals stock now?
What is the ticker symbol for Citius Pharmaceuticals?
The ticker symbol for Citius Pharmaceuticals is NASDAQ:CTXR
Does Citius Pharmaceuticals pay dividends?
No, Citius Pharmaceuticals does not pay dividends
What sector is Citius Pharmaceuticals in?
Citius Pharmaceuticals is in the Healthcare sector
What industry is Citius Pharmaceuticals in?
Citius Pharmaceuticals is in the Biotechnology industry
What country is Citius Pharmaceuticals based in?
Citius Pharmaceuticals is headquartered in United States
When did Citius Pharmaceuticals go public?
Citius Pharmaceuticals's initial public offering (IPO) was on October 2, 2014
Is Citius Pharmaceuticals in the S&P 500?
No, Citius Pharmaceuticals is not included in the S&P 500 index
Is Citius Pharmaceuticals in the NASDAQ 100?
No, Citius Pharmaceuticals is not included in the NASDAQ 100 index
Is Citius Pharmaceuticals in the Dow Jones?
No, Citius Pharmaceuticals is not included in the Dow Jones index
When was Citius Pharmaceuticals's last earnings report?
Citius Pharmaceuticals's most recent earnings report was on Feb 14, 2025
When does Citius Pharmaceuticals report earnings?
The next expected earnings date for Citius Pharmaceuticals is May 14, 2025
Should I buy Citius Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions